1. Pink Sheet
  2. >>Compliance
  3. >>Manufacturing

New African Platform To Build Up Drug Production & Supply Chains

 
• By Ian Schofield

The World Health Organization and its partners in the venture say that Africa’s reliance on pharmaceutical imports is unsustainable, particularly in the face of population growth.

Made in Africa stamp and stamping hand. Factory, manufacturing and production country concept.
Many approaches are being taken to boost African drug manufacturing • Source: Sutterstock

A new initiative has been launched in Africa to help build up drug and vaccine manufacturing capacity, strengthen local supply chains and improve regulatory harmonization, as part of wider efforts to give the continent more autonomy in drug production and supply.

The Health Products Manufacturing Support Platform (HMSP), which was presented at last week’s World Local Production Forum in the Netherlands, is a match-making initiative where African manufacturers can seek assistance in areas such as

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance

Pharma Industry Argues Tax, Other Incentives Better Than Tariffs

 
• By Jessica Merrill

Pharmaceutical industry organizations offered alternatives to tariffs that could maintain a secure domestic supply chain in public comments filed in response to a federal 232 investigation.

US FDA Expands Surprise Foreign Inspections But Loses Associate Commissioner Michael Rogers

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.

Pharma Predicts Modest Tariff Impact, Depending On What Comes Next

 
• By Jessica Merrill

Drugmakers are not expecting a big financial hit from tariffs for now, but a report commissioned by the industry trade association PhRMA suggests a potentially steep cost for pharma-sector tariffs.